ABL1 |
P00519
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
Kinase
|
1.00 |
0.432 |
0.923 |
AKT1 |
P31749
|
AKT serine/threonine kinase 1
|
Kinase
|
0.98 |
0.311 |
0.962 |
AR |
P10275
|
androgen receptor
|
Nuclear receptor
|
0.99 |
0.351 |
0.846 |
ATN1 |
P54259
|
atrophin 1
|
|
1.00 |
0.409 |
0.885 |
BCL2 |
P10415
|
BCL2 apoptosis regulator
|
Signaling
|
0.56 |
0.291 |
0.885 |
BCR |
P11274
|
BCR activator of RhoGEF and GTPase
|
Enzyme modulator
|
0.99 |
0.431 |
0.885 |
CCR7 |
P32248
|
C-C motif chemokine receptor 7
|
G-protein coupled receptor
|
5.8E-02 |
0.443 |
0.769 |
CD47 |
Q08722
|
CD47 molecule
|
|
0.92 |
0.468 |
0.769 |
CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
CSF2 |
P04141
|
colony stimulating factor 2
|
Signaling
|
0.83 |
0.330 |
0.962 |
CSF3 |
P09919
|
colony stimulating factor 3
|
|
0.38 |
0.377 |
0.885 |
CTNNB1 |
P35222
|
catenin beta 1
|
|
1.00 |
0.303 |
0.885 |
DCTN6 |
O00399
|
dynactin subunit 6
|
Cellular structure
|
5.6E-02 |
0.442 |
0.769 |
DKK1 |
O94907
|
dickkopf WNT signaling pathway inhibitor 1
|
|
0.17 |
0.439 |
0.885 |
DNMT3A |
Q9Y6K1
|
DNA methyltransferase 3 alpha
|
|
7.4E-39 |
0.445 |
0.846 |
EPHB2 |
P29323
|
EPH receptor B2
|
Kinase
|
1.00 |
0.374 |
0.846 |
ETV6 |
P41212
|
ETS variant transcription factor 6
|
Transcription factor
|
0.97 |
0.477 |
0.731 |
EZH2 |
Q15910
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
Epigenetic regulator
|
1.00 |
0.376 |
0.885 |
FAS |
P25445
|
Fas cell surface death receptor
|
|
0.81 |
0.372 |
0.923 |
FGFR1 |
P11362
|
fibroblast growth factor receptor 1
|
Kinase
|
1.00 |
0.362 |
0.885 |
FIP1L1 |
Q6UN15
|
factor interacting with PAPOLA and CPSF1
|
|
0.79 |
0.575 |
0.577 |
FLT3 |
P36888
|
fms related receptor tyrosine kinase 3
|
Kinase
|
0.61 |
0.462 |
0.654 |
GSTT1 |
P30711
|
glutathione S-transferase theta 1
|
|
1.5E-04 |
0.393 |
0.923 |
H3P23 |
|
H3 histone pseudogene 23
|
|
|
0.443 |
0.769 |
IDH1 |
O75874
|
isocitrate dehydrogenase (NADP(+)) 1
|
|
2.6E-12 |
0.424 |
0.808 |